HDFC Life Q4 Results: Should you buy, sell or hold largecap insurance stock?

HDFC Life Insurance Company on Thursday reported a largely better-than-expected set of results for the quarter ended March 31, with a 4.0 per cent increase in its standalone net profit to Rs 496 crore. Its fourth-quarter premium income stood at Rs 26,422 crore, up 10 per cent over the year-ago period. While the net profit exceeded Street estimates, the gross premium income almost met the mark. According to Zee Business research, the life insurer was estimated to register a net profit of Rs 480 crore and a gross premium income of Rs 26,670 crore for the final three months of FY26.

Most brokerages remained upbeat about the life insurance company after the earnings announcement, with their targets indicating up to 50 per cent upside in the stock from Thursday's closing price.

The management sounded positive but refrained from giving any guidance for the coming months due to market volatility.

HDFC Life Q4 Earnings | From premium income to operating performance

HDFC Life's total premium income grew 8.7 per cent on a year-on-year basis to Rs 25,829 crore, according to a regulatory filing.

Growth in its annualised premium equivalent (APE) -- a key measure of sales for insurance businesses -- came in at 6.7 per cent for Q4.

The company's value of new business (VNB) -- or the present value of anticipated future profits from new policies sold -- came in at Rs 4,034 crore for FY26, with a margin of 24.2 per cent.

HDFC Life preferential issue

The insurer's board gave the nod to raising up to Rs 1,000 crore by way of a preferential issue to its parent, HDFC Bank, in order to augment its solvency position.

Management commentary

The HDFC Life management noted that its FY27 growth target will outpace industry, with a priority to restore growth momentum.

It expects the impact of GST changes to be fully absorbed in the first half of the current financial year.

HDFC Life dividend

The insurer declared a final dividend of Rs 2.1 per equity share -- a payout of 21 per cent given the face value of Rs 10 per equity share.

Should you buy, sell or hold HDFC Life shares post-Q4 results?

With the Q4 results now out of the way, here's how foreign brokerages including Citi, Goldman Sachs and JPMorgan rate the stock:

Citi, Morgan Stanley, HSBC maintain 'buy' ratings

Citi maintained a 'buy' rating on HDFC Life with a target price of Rs 950 for the HDFC Life stock. The target indicates an upside of 50.4 per cent over the previous close.

According to the brokerage, the insurer is expected to see its margin improve going forward, as it focuses on regaining market dominance post-FY26 challenges.

The company, noted Citi, is in a sweet spot to recoup its business performance.

Morgan Stanley retained its 'buy' call on HDFC Life with a target of Rs 745, indicating an 18 per cent upside.

The quarter was soft on the VNB front, noted the brokerage.

Macquarie kept its 'outperform' rating for the stock with a target of Rs 900, stating that it was a tough quarter and year for the company, with VNB affected by surrender charges and the GST impact.

The brokerage expects HDFC Life's VNB to expand at a CAGR of around 15 per cent over the next three years. It also sees capital-raising to improve its solvency margin by 900 bps.

JPMorgan maintains 'overweight' call

JPMorgan retained its 'overweight' rating on HDFC Life while revising its target downward to Rs 810 from Rs 960.

The brokerage pointed out that the insurer's Q4 APE growth was weak at 0.4 per cent.

While the HDFC Life management is optimistic about pricing rationality returning, near-term competitive intensity is likely to hurt its growth, according to JPMorgan.